Renub Research
www.renub.com
Adult Vaccines Market, Company Adult Vaccines Sales,
Country Adult Vaccines - Worldwide Analy...
World Adult Vaccines Market – Market Overview

For much of the 20th century, vaccines were a pharmaceutical success story ...
Companies’ Adult Vaccines Sales Share and Forecast data (2007 – 2020) covered in the
report
1. GlaxoSmithKline (GSK)
2. Sa...
(Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these
vaccines have been further sub-d...
(Chapter 10): This chapter studies growth Factors Driving the Adult Vaccines Market. In total 8
growth topics have been di...
About Us
Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Ro...
Published
By

Renub Research
1st Floor,
C-86, Sector–10
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-30...
Table of Contents
1.

Executive Summary

2.

World Adult Vaccine Analysis & Forecast (2007 – 2020)
2.1
2.2

3.

World Adul...
5.2.4
5.3

Cervical Cancer/HPV - Number of New Cases & Forecast

Zoster Shingles – Adult Vaccine Analysis (2006 – 2020)

5...
6.2

Sanofi Pasteur

6.2.1

Sanofi Pasteur Vaccines Sales Analysis

6.2.2

Strategic Alliances of Sanofi Pasteur

6.3

Mer...
7.5.1

Pfizer – Pneumococcal Adult Vaccines Sales & Forecast

World Adult Vaccine Market – Geographical Distribution

8.

...
11.2.3

Economic Barriers

11.2.4

Regulatory Barriers

11.3

Shortening the Timeline for Vaccine Development

11.4

Refus...
List of Figures
Figure 2-1: Worldwide – Adult Vaccine Market (Million US$), 2007 – 2012
Figure 2-2: Worldwide – Forecast f...
Figure 5-5: Worldwide – Number of Influenza Vaccine Doses (Million), 2007 – 2012
Figure 5-6: Worldwide – Forecast for Numb...
Figure 5-31: Worldwide – MMRV Adult Vaccine Market (Million US$), 2007 – 2012
Figure 5-32: Worldwide – Forecast for MMRV A...
Figure 7-1: Worldwide – GSK Influenza Adult Vaccines Sales (Million US$), 2007 – 2012
Figure 7-2: Worldwide – Forecast for...
Figure 7-30: Worldwide – Forecast for Novartis Meningococcal Adult Vaccines Sales (Million US$), 2013 –
2020
Figure 7-31: ...
List of Tables
Table 3-1: Worldwide – Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2010 – 2012
Table 3-...
Order Form
Scan and e-mail this page to info@renub.com. Else you can also fax this form to +91-120-4249780
Questions? Plea...
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Ba...
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor,
C-86, Sec...
Upcoming SlideShare
Loading in …5
×

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis

602 views
497 views

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
602
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis

  1. 1. Renub Research www.renub.com Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis Influenza … Cervical Cancer/ HPV … Hepatitis … Zoster Shingles … Pneumococcal … Measles, Mumps, Rubella and Varicella (MMRV) … Meningococcal … Diphtheria, Tetanus, Pertussis (DTP) … Travel and Miscellaneous Published: November, 2013 Copyright © 2013 Renub Research – All Rights Reserved
  2. 2. World Adult Vaccines Market – Market Overview For much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles, and other diseases. While Pediatric Vaccines are an important market, it is now adults who are fueling growth of vaccine products. The world adult vaccines market is expected to nearly double by 2020 from the current figure of 2012. Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine preventable diseases and their resulting deaths are now rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry. Renub Research study titled “Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Adult Vaccines Landscape. This 222 page report with 142 Figures and 15 Tables studies: 9 Adult Vaccines Market, 5 Companies Adult Vaccines Sales. In total 28 Adult Vaccines have been researched for this report. This report is broadly divided into 11 chapters. Adult Vaccines Market & Forecast data (2007 – 2020) covered in the report are as follows: 1. Influenza 2. Cervical Cancer/ HPV 3. Hepatitis 4. Zoster Shingles 5. Pneumococcal 6. Measles, Mumps, Rubella and Varicella (MMRV) 7. Meningococcal 8. Diphtheria, Tetanus, Pertussis (DTP) 9. Travel and Miscellaneous © Renub Research Page 2 of 21
  3. 3. Companies’ Adult Vaccines Sales Share and Forecast data (2007 – 2020) covered in the report 1. GlaxoSmithKline (GSK) 2. Sanofi Pasteur 3. Merck 4. Novartis 5. Pfizer 6. Others (Chapter 1): Executive Summary (Chapter 2): This Chapter is divided into 2 parts A. Adult Vaccines Market and Forecast data from 2007 to 2020 B. Adult Vaccinated Number and Forecast from 2007 to 2020 (Chapter 3): This chapter is divided into 3 parts A. Provides market share (percentage) of Adult Vaccines in the above mentioned vaccines B. Provides market share (percentage) of Adult Vaccinated in the above mentioned vaccines C. Provides above mentioned companies market share in Adult vaccines. (Chapter No. 4): This chapter is divided into 2 parts A. Companies given above Sales Share (percentage) in Disease Wise Break up & Forecast B. Adult Vaccines given above Companies Share and Forecast © Renub Research Page 3 of 21
  4. 4. (Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these vaccines have been further sub-divided into 4 parts A. Adult Vaccine Market & Forecast B. Number of Adults Being Vaccinated & Forecast C. Number of Adult Vaccines Doses & Forecast D. Number of Cases (Chapter 6): This chapter studies mentioned above all the 5 companies Adult Vaccines Sales and Forecast. The chapter further talks about the Company alliances with other Companies in order to increase their vaccine sales. (Chapter 7): This chapter studies mentioned above all the 5 companies’ Sales and Forecast Disease Wise (Chapter 8): This chapter provides Adult Vaccines Market and Forecast data of 8 Geographic Regions Worldwide. 1. United States 2. North America/Caribbean 3. South America 4. Europe 5. Japan 6. India 7. China 8. Rest of the World (ROW) (Chapter 9): This chapter comprises of important Mergers and Acquisitions happening in the field of vaccines © Renub Research Page 4 of 21
  5. 5. (Chapter 10): This chapter studies growth Factors Driving the Adult Vaccines Market. In total 8 growth topics have been discussed in this chapter. (Chapter 11): This chapter studies Challenges/Hindrances faced by Adult Vaccines Market. In total 7 challenges topics have been discussed in this chapter Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. © Renub Research Page 5 of 21
  6. 6. About Us Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets. For more information on us or to view any of our sample work you can mail us at info@renub.com © Renub Research Page 6 of 21
  7. 7. Published By Renub Research 1st Floor, C-86, Sector–10 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com © Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines Worldwide Analysis Renub Research, 2013 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers © Renub Research Page 7 of 21
  8. 8. Table of Contents 1. Executive Summary 2. World Adult Vaccine Analysis & Forecast (2007 – 2020) 2.1 2.2 3. World Adult Vaccine – Market & Forecast World Adult Vaccine – Number of Adults Being Vaccinated & Forecast World Adult Vaccine Market Share Analysis & Forecast (2010 – 2020) 3.1 3.2 Disease Wise – Percentage of Adults Being Vaccinated Share & Forecast (2010 – 2020) 3.3 4. Disease Wise – Market Share & Forecast (2010 – 2020) Company Wise – Market Share & Forecast (2010 – 2020) World Adult Vaccine Sales – Company Analysis Share & Forecast (2010 – 2020) 4.1 Companies Adult Vaccine Sales – Disease Wise Break up Share & Forecast (2010 – 2020) 4.1.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales Share & Forecast 4.1.2 Sanofi Pasteur - Adult Vaccines Sales Share & Forecast 4.1.3 Merck - Adult Vaccines Sales Share & Forecast 4.1.4 Novartis - Adult Vaccines Sales Share & Forecast 4.2 Adult Vaccine Disease Wise Market Break up - Company Share & Forecast (2010 – 2020) 4.2.1 4.2.2 Cervical Cancer/HPV Adult Vaccines – Company Market Share 4.2.3 Hepatitis Adult Vaccines – Company Market Share & Forecast 4.2.4 Pneumococcal Adult Vaccines – Company Market Share & Forecast 4.2.5 Meningococcal Adult Vaccines – Company Market Share & Forecast 4.2.6 5. Influenza Adult Vaccines – Company Market Share DTP (Diphtheria, Tetanus, Pertussis) Adult Vaccines – Company Market Share & Forecast World Adult Vaccine Market – Disease Wise Segmentation Analysis 5.1 Influenza Adult Vaccine Analysis & Forecast (2007 – 2020) 5.1.1 Influenza – Adult Vaccine Market & Forecast 5.1.2 Influenza – Number of Adults Being Vaccinated & Forecast 5.1.3 Influenza – Number of Vaccines Doses & Forecast 5.2 Cervical Cancer/ HPV Analysis (2007 – 2020) 5.2.1 Cervical Cancer/ HPV – Adult Vaccine Market & Forecast 5.2.2 Cervical Cancer/ HPV – Number of Adults Being Vaccinated & Forecast 5.2.3 Cervical Cancer/ HPV – Number of Vaccines Doses & Forecast © Renub Research Page 8 of 21
  9. 9. 5.2.4 5.3 Cervical Cancer/HPV - Number of New Cases & Forecast Zoster Shingles – Adult Vaccine Analysis (2006 – 2020) 5.3.1 Zoster Shingles – Adult Vaccine Market & Forecast 5.3.2 Zoster Shingles – Number of Adults Being Vaccinated & Forecast 5.3.3 Zoster Shingles – Number of Vaccine Doses & Forecast 5.4 Pneumococcal – Adult Vaccine Analysis (2010 – 2020) 5.4.1 Pneumococcal – Adult Vaccine Market & Forecast 5.4.2 Pneumococcal – Number of Adults Being Vaccinated & Forecast 5.4.3 Pneumococcal – Number of Vaccine Doses & Forecast 5.5 Meningococcal – Adult Vaccine Analysis 5.5.1 Meningococcal – Adult Vaccine Market & Forecast 5.5.2 Meningococcal – Number of Adults Being Vaccinated & Forecast 5.5.3 Meningococcal – Number of Vaccines Doses & Forecast 5.6 Measles, Mumps, Rubella and Varicella (MMRV) – Adult Vaccine Analysis 5.6.1 Measles, Mumps, Rubella and Varicella (MMRV) – Adult Vaccine Market & Forecast 5.6.2 Measles, Mumps, Rubella and Varicella (MMRV) – Number of Adults Being Vaccinated & Forecast 5.6.3 Measles, Mumps, Rubella and Varicella (MMRV) – Number of Vaccines Doses & Forecast 5.6.4 MMR - Number of New Cases & Forecast 5.7 Hepatitis – Adult Vaccine Market Analysis 5.7.1 Hepatitis – Adult Vaccine Market & Forecast 5.7.2 Hepatitis – Number of Adults Being Vaccinated & Forecast 5.7.3 Hepatitis – Number of vaccine Doses & Forecast 5.7.4 Hepatitis – Number of Acute (New) Cases 5.8 Diphtheria, Tetanus, Pertussis (DTP) – Adult Vaccine Market Analysis 5.8.1 DTP (Diphtheria, Tetanus, Pertussis) – Adult Vaccine Market & Forecast 5.8.2 Diphtheria, Tetanus, Pertussis (DTP) – Number of Adults Being Vaccinated & Forecast 5.8.3 DTP - Number of Vaccines Doses & Forecast 5.8.4 Diphtheria, Tetanus & Pertussis (DTP) - Number of Cases 5.9 6. Travel and Miscellaneous – Adult Vaccine Market World Adult Vaccine Market – Company Analysis & Strategic Alliances 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline (GSK) - Adult Vaccine Sales & Forecast 6.1.2 Strategic Alliances of GlaxoSmithKline (GSK) © Renub Research Page 9 of 21
  10. 10. 6.2 Sanofi Pasteur 6.2.1 Sanofi Pasteur Vaccines Sales Analysis 6.2.2 Strategic Alliances of Sanofi Pasteur 6.3 Merck 6.3.1 Merck Vaccines Sales Analysis 6.3.2 Strategic Alliances of Merck 6.4 Novartis 6.4.1 Novartis Vaccines Sales Analysis 6.4.2 Strategic Alliances of Novartis 6.5 Pfizer 6.5.1 Pfizer Adult Vaccines Sales & Forecast 6.5.2 Strategic Alliances of Pfizer 6.6 7. Other Companies World Adult Vaccine – Company Sales Disease Wise Break up & Forecast (2007 – 2020) 7.1 GlaxoSmithKline (GSK) – Adult Vaccines Sales & Forecast 7.1.1 GlaxoSmithKline (GSK) – Influenza Adult Vaccines Sales & Forecast 7.1.2 GlaxoSmithKline (GSK) – Cervical Cancer/HPV Adult Vaccines Sales & Forecast 7.1.3 GlaxoSmithKline (GSK) – Hepatitis Adult Vaccines Sales & Forecast 7.1.4 GlaxoSmithKline (GSK) – DTP Adult Vaccines Sales & Forecast 7.2 Sanofi Pasteur – Adult Vaccines Sales & Forecast 7.2.1 Sanofi Pasteur – Influenza Adult Vaccines Sales & Forecast 7.2.2 Sanofi Pasteur – DTP Adult Vaccines Sales & Forecast 7.2.3 Sanofi Pasteur – Meningococcal Adult Vaccines Sales & Forecast 7.3 Merck – Adult Vaccines Sales & Forecast 7.3.1 Merck – Influenza Adult Vaccines Sales & Forecast 7.3.2 Merck – Cervical Cancer/HPV Adult Vaccines Sales & Forecast 7.3.3 Merck – Zoster Shingles Adult Vaccines Sales & Forecast 7.3.4 Merck – Pneumococcal Adult Vaccines Sales & Forecast 7.3.5 Merck – MMRV Adult Vaccines Sales & Forecast 7.3.6 Merck – Hepatitis Adult Vaccines Sales & Forecast 7.4 Novartis – Adult Vaccines Sales & Forecast 7.4.1 Novartis – Influenza Adult Vaccines Sales & Forecast 7.4.2 Novartis – Meningococcal Adult Vaccines Sales & Forecast 7.5 Pfizer – Adult Vaccines Sales & Forecast © Renub Research Page 10 of 21
  11. 11. 7.5.1 Pfizer – Pneumococcal Adult Vaccines Sales & Forecast World Adult Vaccine Market – Geographical Distribution 8. 8.1 United States – Adult Vaccine Market & Forecast 8.2 North America/Caribbean – Adult Vaccine Market & Forecast 8.3 South America – Adult Vaccine Market & Forecast 8.4 Europe – Adult Vaccine Market & Forecast 8.5 Japan – Adult Vaccine Market & Forecast 8.6 India – Adult Vaccine Market & Forecast 8.7 China – Adult Vaccine Market & Forecast 8.8 Rest of the World (ROW) – Adult Vaccine Market & Forecast 9. Major Vaccine Related Acquisitions (2005-2012) 10. Growth Factors for Adult Vaccines 10.1 Global Immunization Vision and Strategy (GIVS) 10.2 GAVI Model Fuelling Vaccine Manufacturers 10.2.1 The Partnership Model 10.2.2 The Business Model 10.3 Increasing Vaccine Availability in United States 10.4 The Vaccine Safety Data link Project 10.5 The Vaccine Injury Compensation Program 10.6 Transforming of Vaccine Technologies 10.7 Global Vaccine Action Plan by WHO (2011 - 2020) 10.8 Continuous Focus on Effective Communication Strategies 11. Challenges for Adult Vaccines Market 11.1 Hurdles to Optimal use of Licensed Vaccines 11.1.1 Technical Obstacles 11.1.2 Economic obstacles 11.1.3 Cultural Obstacles 11.2 Complexity of Vaccine Development & Approval System Thwarts Product Development 11.2.1 Legal Obstacles 11.2.2 General Technical Barriers © Renub Research Page 11 of 21
  12. 12. 11.2.3 Economic Barriers 11.2.4 Regulatory Barriers 11.3 Shortening the Timeline for Vaccine Development 11.4 Refusal/Resistance to Vaccination 11.4.1 Vaccine Adverse Event Reporting System 11.5 Vaccine Shortages and Delays 11.6 Obstacles in Vaccine Research & Development 11.7 Barriers to New Entrants in the Vaccines Market © Renub Research Page 12 of 21
  13. 13. List of Figures Figure 2-1: Worldwide – Adult Vaccine Market (Million US$), 2007 – 2012 Figure 2-2: Worldwide – Forecast for Adult Vaccine Market (Million US$), 2013 – 2020 Figure 2-3: Worldwide – Number of Adults Being Vaccinated with Adult Vaccines (Million), 2007 – 2012 Figure 2-4: Worldwide – Forecast for Number of Adults Being Vaccinated with Adult Vaccines (Million), 2013 – 2020 Figure 3-1: Worldwide – Diseases Wise Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 3-2: Worldwide – Forecast for Diseases Wise Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 3-3: Worldwide – Company Wise Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 3-4: Worldwide – Forecast for Company Wise Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-1: Worldwide – GSK Adult Vaccine Sales Share (Percent), 2007 – 2012 Figure 4-2: Worldwide – Forecast for GSK Adult Vaccine Sales Share (Percent), 2013 – 2020 Figure 4-3: Worldwide – Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2010 – 2012 Figure 4-4: Worldwide – Forecast for Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2013 – 2020 Figure 4-5: Worldwide – Merck Adult Vaccine Sales Share (Percent), 2010 – 2012 Figure 4-6: Worldwide – Forecast for Merck Adult Vaccine Sales Share (Percent), 2013 – 2020 Figure 4-7: Worldwide – Forecast for Novartis Adult Vaccine Sales Share (Percent), 2010 – 2012 Figure 4-8: Worldwide – Forecast for Novartis Adult Vaccine Sales Share (Percent), 2013 – 2020 Figure 4-9: Worldwide – Influenza Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 4-10: Worldwide – Forecast for Influenza Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-11: Worldwide – Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2007 – 2012 Figure 4-12: Worldwide – Forecast for Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-13: Worldwide – Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2008 – 2012 Figure 4-14: Worldwide – Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-15: Worldwide – Pneumococcal Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 4-16: Worldwide – Forecast for Pneumococcal Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-17: Worldwide – Meningococcal Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 4-18: Worldwide – Forecast for Meningococcal Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 4-19: Worldwide – DTP Adult Vaccine Market Share (Percent), 2010 – 2012 Figure 4-20: Worldwide – Forecast for DTP Adult Vaccine Market Share (Percent), 2013 – 2020 Figure 5-1: Worldwide – Influenza Adult Vaccine Market (Million US$), 2007 – 2012 Figure 5-2: Worldwide – Forecast for Influenza Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-3: Worldwide – Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2007 – 2012 Figure 5-4: Worldwide – Forecast for Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2013 – 2020 © Renub Research Page 13 of 21
  14. 14. Figure 5-5: Worldwide – Number of Influenza Vaccine Doses (Million), 2007 – 2012 Figure 5-6: Worldwide – Forecast for Number of Influenza Vaccine Doses (Million), 2013 – 2020 Figure 5-7: Worldwide – Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2007 – 2012 Figure 5-8: Worldwide – Forecast for Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-9: Worldwide – Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2007 – 2012 Figure 5-10: Worldwide – Forecast for Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2013 – 2020 Figure 5-11: Worldwide – Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2007 – 2012 Figure 5-12: Worldwide – Forecast for Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2013 – 2020 Figure 5-13: Worldwide – Zoster Shingles Adult Vaccine Market (Million US$), 2006 – 2012 Figure 5-14: Worldwide – Forecast for Zoster Shingles Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-15: Worldwide – Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2006 – 2012 Figure 5-16: Worldwide – Forecast for Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2013 – 2020 Figure 5-17: Worldwide – Number of Zoster Shingles Vaccine Doses (Million US$), 2007 – 2012 Figure 5-18: Worldwide – Forecast for Number of Zoster Shingles Vaccine Doses (Million US$), 2013 – 2020 Figure 5-19: Worldwide – Pneumococcal Adult Vaccine Market (Million US$), 2010 – 2012 Figure 5-20: Worldwide – Forecast for Pneumococcal Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-21: Worldwide – Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2010 – 2012 Figure 5-22: Worldwide – Forecast for Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2013 – 2020 Figure 5-23: Worldwide – Number of Pneumococcal Vaccines Doses (Million), 2010 – 2012 Figure 5-24: Worldwide – Forecast for Number of Pneumococcal Vaccines Doses (Million), 2013 – 2020 Figure 5-25: Worldwide – Meningococcal Adult Vaccine Market (Million US$), 2010 – 2012 Figure 5-26: Worldwide – Forecast for Meningococcal Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-27: Worldwide – Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2010 – 2012 Figure 5-28: Worldwide – Forecast for Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2013 – 2020 Figure 5-29: Worldwide – Number of Meningococcal Vaccines Doses (Million), 2010 – 2012 Figure 5-30: Worldwide – Forecast for Number of Meningococcal Vaccines Doses (Million), 2013 – 2020 © Renub Research Page 14 of 21
  15. 15. Figure 5-31: Worldwide – MMRV Adult Vaccine Market (Million US$), 2007 – 2012 Figure 5-32: Worldwide – Forecast for MMRV Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-33: Worldwide – Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2007 – 2012 Figure 5-34: Worldwide – Forecast for Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2013 – 2020 Figure 5-35: Worldwide – Number of MMRV Vaccines Doses (Million), 2007 – 2012 Figure 5-36: Worldwide – Forecast for Number of MMRV Vaccines Doses (Million), 2013 – 2020 Figure 5-37: Worldwide – Hepatitis Adult Vaccine Market (Million US$), 2007 – 2012 Figure 5-38: Worldwide – Forecast for Hepatitis Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-39: Worldwide – Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2007 – 2012 Figure 5-40: Worldwide – Forecast for Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2013 – 2020 Figure 5-41: Worldwide – Number of Hepatitis Vaccines Doses (Million), 2007 – 2012 Figure 5-42: Worldwide – Forecast for Number of Hepatitis Vaccines Doses (Million), 2013 – 2020 Figure 5-43: United States – Reported Acute (New) Cases of Hepatitis A Virus (Number), 2005 – 2011 Figure 5-44: United States – Reported Acute (New) Cases of Hepatitis B Virus (Number), 2005 – 2011 Figure 5-45: Worldwide – DTP Adult Vaccine Market (Million US$), 2010 – 2012 Figure 5-46: Worldwide – Forecast for DTP Adult Vaccine Market (Million US$), 2013 – 2020 Figure 5-47: Worldwide – Number of Adults Being Vaccinated with DTP Vaccines (Million), 2010 – 2012 Figure 5-48: Worldwide – Forecast for Number of Adults Being Vaccinated with DTP (Million), 2013 – 2020 Figure 5-49: Worldwide – Number of DTP Vaccine Doses (Million), 2010 – 2012 Figure 5-50: Worldwide – Forecast for Number of DTP Vaccine Doses (Million), 2013 – 2020 Figure 5-51: Worldwide – Travel and Misc. Adult Vaccine Market (Million US$), 2007 – 2012 Figure 5-52: Worldwide – Forecast For Travel and Misc. Adult Vaccine Market (Million US$), 2013 – 2020 Figure 6-1: Worldwide – GlaxoSmithKline Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 6-2: Worldwide – Forecast for GlaxoSmithKline Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 6-3: Worldwide – Sanofi Pasteur Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 6-4: Worldwide – Forecast for Sanofi Pasteur Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 6-5: Worldwide – Merck Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 6-6: Worldwide – Forecast for Merck Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 6-7: Worldwide – Novartis Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 6-8: Worldwide – Forecast for Novartis Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 6-9: Worldwide – Pfizer Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 6-10: Worldwide – Forecast for Pfizer Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 6-11: Worldwide – Other Companies Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 6-12: Worldwide – Forecast for Other Companies Adult Vaccines Sales (Million US$), 2013 – 2020 © Renub Research Page 15 of 21
  16. 16. Figure 7-1: Worldwide – GSK Influenza Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-2: Worldwide – Forecast for GSK Influenza Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-3: Worldwide – GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-4: Worldwide – Forecast for GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-5: Worldwide – GSK Hepatitis Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-6: Worldwide – Forecast for GSK Hepatitis Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-7: Worldwide – GSK DTP Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-8: Worldwide – Forecast for GSK DTP Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-9: Worldwide – Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2009 – 2012 Figure 7-10: Worldwide – Forecast for Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-11: Worldwide – Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 7-12: Worldwide – Forecast for Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-13: Worldwide – Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2009 – 2012 Figure 7-14: Worldwide – Forecast for Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-15: Worldwide – Merck Influenza Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 7-16: Worldwide – Forecast for Merck Influenza Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-17: Worldwide – Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-18: Worldwide – Forecast for Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-19: Worldwide – Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-20: Worldwide – Forecast for Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-21: Worldwide – Merck Pneumococcal Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-22: Worldwide – Forecast for Merck Pneumococcal Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-23: Worldwide – Merck MMRV Adult Vaccines Sales (Million US$), 2007 – 2012 Figure 7-24: Worldwide – Forecast for Merck MMRV Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-25: Worldwide – Merck Hepatitis Adult Vaccines Sales (Million US$), 2008 – 2012 Figure 7-26: Worldwide – Forecast for Merck Hepatitis Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-27: Worldwide – Novartis Influenza Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 7-28: Worldwide – Forecast for Novartis Influenza Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-29: Worldwide – Novartis Meningococcal Adult Vaccines Sales (Million US$), 2010 – 2012 © Renub Research Page 16 of 21
  17. 17. Figure 7-30: Worldwide – Forecast for Novartis Meningococcal Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 7-31: Worldwide – Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2010 – 2012 Figure 7-32: Worldwide – Forecast for Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2013 – 2020 Figure 8-1: United States – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-2: United States – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-3: North America/Caribbean – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-4: North America/Caribbean – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-5: South America – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-6: South America – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-7: Europe – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-8: Europe – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-9: Japan – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-10: Japan – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-11: India – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-12: India – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-13: China – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-14: China – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 8-15: ROW – Adult Vaccines Market (Million US$), 2007 – 2012 Figure 8-16: ROW – Forecast for Adult Vaccines Market (Million US$), 2013 – 2020 Figure 10-1: Increasing Number of GAVI Suppliers Based in Emerging Markets, 2001 – 2011 Figure 10-2: US – Number of Retail Clinics offering Vaccination (Number), 2007 – 2012 © Renub Research Page 17 of 21
  18. 18. List of Tables Table 3-1: Worldwide – Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2010 – 2012 Table 3-2: Worldwide – Forecast for Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2013 – 2020 Table 5-1: Cervical Cancer – Region Wise Number of New Cancer Cases (Number), 2009 – 2012 Table 5-2: Cervix – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2018 Table 5-3: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2012 Table 5-4: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2012 Table 5-5: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011 Table 5-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2012 Table 5-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2012 Table 5-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2012 Table 5-9: Worldwide (By Geographic Region) – Number of Pertussis Cases (Number), 2001 – 2012 Table 9-1: Worldwide – Major Vaccine Related Acquisitions, (2005 – 2012) Table 10-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020 Table 10-2: Goal-Level Indicators, 2015 & 2020 Table 10-3: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations © Renub Research Page 18 of 21
  19. 19. Order Form Scan and e-mail this page to info@renub.com. Else you can also fax this form to +91-120-4249780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com Format Report Title: Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis Single User (Email from Publisher) Hard Copy (Mail Delivery) CD – Rom (Mail Delivery) Global Site License (Multiple User License) US$ 1,990 US$ 2,240 US$ 2,090 US$ 2,800 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/adult-vaccines-market-company-adult-vaccines-sales-countryadult-vaccines---worldwide-analysis-126 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=126&pid=1501 To pay by Wire Transfer, please, fill in your contact details in the form below: © Renub Research Page 19 of 21
  20. 20. Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: © Renub Research Page 20 of 21
  21. 21. 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch © Renub Research Page 21 of 21

×